These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32353488)

  • 1. Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies.
    Pereira-Silva M; Jarak I; Alvarez-Lorenzo C; Concheiro A; Santos AC; Veiga F; Figueiras A
    J Control Release; 2020 Jul; 323():442-462. PubMed ID: 32353488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micelleplex-based nucleic acid therapeutics: From targeted stimuli-responsiveness to nanotoxicity and regulation.
    Pereira-Silva M; Jarak I; Santos AC; Veiga F; Figueiras A
    Eur J Pharm Sci; 2020 Oct; 153():105461. PubMed ID: 32653564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antitumor efficacy of redox and pH dually responsive micelleplexes for co-delivery of camptothecin and genes.
    Chen M; Zhang Y; Chen Z; Xie S; Luo X; Li X
    Acta Biomater; 2017 Feb; 49():444-455. PubMed ID: 27940163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(2-ethyl-2-oxazoline)-PLA-g-PEI amphiphilic triblock micelles for co-delivery of minicircle DNA and chemotherapeutics.
    Gaspar VM; Gonçalves C; de Melo-Diogo D; Costa EC; Queiroz JA; Pichon C; Sousa F; Correia IJ
    J Control Release; 2014 Sep; 189():90-104. PubMed ID: 24984013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Length-Controlled Nanofiber Micelleplexes as Efficient Nucleic Acid Delivery Vehicles.
    Street STG; Chrenek J; Harniman RL; Letwin K; Mantell JM; Borucu U; Willerth SM; Manners I
    J Am Chem Soc; 2022 Nov; 144(43):19799-19812. PubMed ID: 36260789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine in osteosarcoma therapy: Micelleplexes for delivery of nucleic acids and drugs toward osteosarcoma-targeted therapies.
    Pereira-Silva M; Alvarez-Lorenzo C; Concheiro A; Santos AC; Veiga F; Figueiras A
    Eur J Pharm Biopharm; 2020 Mar; 148():88-106. PubMed ID: 31958514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.
    Yu H; Guo C; Feng B; Liu J; Chen X; Wang D; Teng L; Li Y; Yin Q; Zhang Z; Li Y
    Theranostics; 2016; 6(1):14-27. PubMed ID: 26722370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart micelleplexes as a new therapeutic approach for RNA delivery.
    Pereira P; Barreira M; Queiroz JA; Veiga F; Sousa F; Figueiras A
    Expert Opin Drug Deliv; 2017 Mar; 14(3):353-371. PubMed ID: 27434618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
    Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
    Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
    Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
    Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
    Iyer AK; Duan Z; Amiji MM
    Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
    Bartlett DW; Davis ME
    Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of precision nanofiber micelleplexes for DNA delivery.
    Street STG; Parkin HC; Shopperly L; Chrenek J; Letwin K; Willerth SM; Manners I
    Biomater Sci; 2023 May; 11(10):3512-3523. PubMed ID: 36992650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
    Xu L; Anchordoquy T
    J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo application of RNA interference: from functional genomics to therapeutics.
    Lu PY; Xie F; Woodle MC
    Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymers in the Delivery of siRNA for the Treatment of Virus Infections.
    Reynolds N; Dearnley M; Hinton TM
    Top Curr Chem (Cham); 2017 Apr; 375(2):38. PubMed ID: 28324594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycation Architecture and Assembly Direct Successful Gene Delivery: Micelleplexes Outperform Polyplexes via Optimal DNA Packaging.
    Tan Z; Jiang Y; Zhang W; Karls L; Lodge TP; Reineke TM
    J Am Chem Soc; 2019 Oct; 141(40):15804-15817. PubMed ID: 31553590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge.
    Colombo S; Zeng X; Ragelle H; Foged C
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1481-95. PubMed ID: 24950005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.